Articles and Insights

Medical device manufacturers operating globally face a growing challenge: post-market surveillance systems that satisfy EU MDR requirements do not automatically meet FDA expectations under the new QMSR.

See how nanotechnology drives drug-delivery innovation, and how intellectual property and market research insight help companies stay ahead.

Learn why monitoring who cites your patents protects your intellectual property, reveals new opportunities, and strengthens your patent strategy.

While specific requirements vary by market, it is clear that post-market surveillance limited to collection of customer complaints, or reactive post-market surveillance, is not adequate.

Scopus-based mapping of 2023–2025 research to help R&D and sustainability leaders identify universities, start-ups, and technology developers worth partnering with.